Trial Profile
Randomized, Open-Label Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2019
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary) ; Venlafaxine (Primary)
- Indications Hot flashes
- Focus Therapeutic Use
- 17 Feb 2012 New trial record